Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.06 | 0.02 |
| FCF Yield | 0.00% | -122.42% | -67.19% | -20.42% |
| EV / EBITDA | -0.78 | -0.98 | -2.35 | -5.87 |
| Quality | ||||
| ROIC | -68.67% | -49.76% | -50.48% | -76.52% |
| Gross Margin | -604.72% | -524.19% | -1,073.14% | -1,183.49% |
| Cash Conversion Ratio | 0.51 | 0.86 | 0.98 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | 29.50% | 13.35% | -2.66% | -16.70% |
| Free Cash Flow Growth | 43.82% | 26.68% | -75.43% | -6.36% |
| Safety | ||||
| Net Debt / EBITDA | -0.78 | -0.17 | -0.66 | -1.20 |
| Interest Coverage | -23.21 | -27.21 | -14.97 | -54.66 |
| Efficiency | ||||
| Inventory Turnover | 18.36 | 12.68 | 11.29 | 18.33 |
| Cash Conversion Cycle | 94.72 | 287.51 | 387.71 | 265.93 |